{"id":"https://openalex.org/W4361241035","doi":"https://doi.org/10.1158/0008-5472.c.6503996","title":"Data from A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease","display_name":"Data from A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4361241035","doi":"https://doi.org/10.1158/0008-5472.c.6503996"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6503996","doi":"https://doi.org/10.1158/0008-5472.c.6503996","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6503996","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/0008-5472.c.6503996","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052306881","display_name":"Diego J. Laderach","orcid":"https://orcid.org/0000-0002-2205-0899","observed_orcids":["https://orcid.org/0000-0002-2205-0899"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diego J. Laderach","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058655914","display_name":"Lucas D. Gentilini","orcid":"https://orcid.org/0000-0002-2886-4084","observed_orcids":["https://orcid.org/0000-0002-2886-4084"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lucas D. Gentilini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078188705","display_name":"Laura Giribaldi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura Giribaldi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005166546","display_name":"V\u00edctor M. C\u00e1rdenas Delgado","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Victor Cardenas Delgado","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066089550","display_name":"Lorena Nugnes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lorena Nugnes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078783643","display_name":"Diego Omar Croci","orcid":"https://orcid.org/0000-0002-8623-0645","observed_orcids":["https://orcid.org/0000-0002-8623-0645"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diego O. Croci","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088300469","display_name":"Nader Al Nakouzi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nader Al Nakouzi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009723096","display_name":"PAULA ALEJANDRA SACCA","orcid":"https://orcid.org/0000-0002-2681-1026","observed_orcids":["https://orcid.org/0000-0002-2681-1026"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paula Sacca","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105783249","display_name":"Gabriel Casas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabriel Casas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080516250","display_name":"Osvaldo Mazza","orcid":"https://orcid.org/0000-0002-1994-8411","observed_orcids":["https://orcid.org/0000-0002-1994-8411"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Osvaldo Mazza","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021363179","display_name":"Margaret Ann Shipp","orcid":"https://orcid.org/0000-0002-3949-6897","observed_orcids":["https://orcid.org/0000-0002-3949-6897"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Margaret A. Shipp","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068896144","display_name":"Elba Susana Vazquez","orcid":"https://orcid.org/0000-0002-0460-0236","observed_orcids":["https://orcid.org/0000-0002-0460-0236"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elba Vazquez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085263324","display_name":"Anne Chauchereau","orcid":"https://orcid.org/0000-0001-9447-3797","observed_orcids":["https://orcid.org/0000-0001-9447-3797"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Chauchereau","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005876566","display_name":"Jeffery Lorne Kutok","orcid":"https://orcid.org/0009-0009-9931-3106","observed_orcids":["https://orcid.org/0009-0009-9931-3106"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffery L. Kutok","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058975989","display_name":"Scott J. Rodig","orcid":"https://orcid.org/0000-0003-1761-9769","observed_orcids":["https://orcid.org/0000-0003-1761-9769"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Scott J. Rodig","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016346855","display_name":"Mar\u00eda Teresa Elola","orcid":"https://orcid.org/0000-0002-0767-3772","observed_orcids":["https://orcid.org/0000-0002-0767-3772"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mar\u00eda T. Elola","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011774712","display_name":"Daniel Compagno","orcid":"https://orcid.org/0000-0002-7589-7217","observed_orcids":["https://orcid.org/0000-0002-7589-7217"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Compagno","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5024226262","display_name":"Gabriel A. Rabinovich","orcid":"https://orcid.org/0000-0002-0947-8735","observed_orcids":["https://orcid.org/0000-0002-0947-8735"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabriel A. Rabinovich","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12387","display_name":"Galectins and Cancer Biology","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12387","display_name":"Galectins and Cancer Biology","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11142","display_name":"Advanced Glycation End Products research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/galectin-1","display_name":"galectin-1","score":0.8299999833106995},{"id":"https://openalex.org/keywords/galectins","display_name":"galectins","score":0.8690000176429749},{"id":"https://openalex.org/keywords/prostate-cancer-progression","display_name":"prostate cancer progression","score":0.9480000138282776},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.871999979019165},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.7570000290870667},{"id":"https://openalex.org/keywords/tumor-vascularization","display_name":"tumor vascularization","score":0.6129999756813049},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9430000185966492},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.9179999828338623},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.5210000276565552},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.6129999756813049}],"concepts":[{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.8810579776763916},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.7094929218292236},{"id":"https://openalex.org/C156293190","wikidata":"https://www.wikidata.org/wiki/Q83138026","display_name":"Galectin","level":2,"score":0.6297043561935425},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6064833998680115},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5393092632293701},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.536204993724823},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.499614953994751},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.4824255406856537},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.47865140438079834},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.46191883087158203},{"id":"https://openalex.org/C87874733","wikidata":"https://www.wikidata.org/wiki/Q18039844","display_name":"PCA3","level":4,"score":0.4513685405254364},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.4508898854255676},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.42635613679885864},{"id":"https://openalex.org/C119056186","wikidata":"https://www.wikidata.org/wiki/Q1431332","display_name":"Gene silencing","level":3,"score":0.4108573794364929},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30901211500167847},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2675302028656006},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2324327826499939},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.12438687682151794},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.11469203233718872},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10198518633842468},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.0},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/0008-5472.c.6503996","doi":"https://doi.org/10.1158/0008-5472.c.6503996","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6503996","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/0008-5472.c.6503996.v1","doi":"https://doi.org/10.1158/0008-5472.c.6503996.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6503996.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6503996","doi":"https://doi.org/10.1158/0008-5472.c.6503996","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6503996","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2101854789","https://openalex.org/W2071949511","https://openalex.org/W2046615425","https://openalex.org/W2055623823","https://openalex.org/W2048291886","https://openalex.org/W2046229657","https://openalex.org/W2159354725","https://openalex.org/W7101067336","https://openalex.org/W2063806777","https://openalex.org/W1483678763"],"abstract_inverted_index":{"Abstract":[0],"Galectins,":[1],"a":[2,213,228,234],"family":[3],"of":[4,27,36,56,66,89,136,144,163,183,190,205,243],"glycan-binding":[5],"proteins,":[6],"influence":[7],"tumor":[8,31,42,200],"progression":[9,149],"by":[10],"modulating":[11],"interactions":[12],"between":[13],"tumor,":[14],"endothelial,":[15],"stromal,":[16],"and":[17,72,78,83,107,127,150,225],"immune":[18],"cells.":[19],"Despite":[20],"considerable":[21],"progress":[22],"in":[23,30,40,103,167,187,195,222,240],"identifying":[24],"the":[25,37,53,57,63,90,98,141,155,160,181,191,244],"roles":[26],"individual":[28],"galectins":[29,118],"biology,":[32],"an":[33],"integrated":[34],"portrait":[35],"galectin":[38,102],"network":[39],"different":[41,87],"microenvironments":[43],"is":[44],"still":[45],"missing.":[46],"We":[47],"undertook":[48],"this":[49,164],"study":[50],"to":[51],"analyze":[52],"\u201cgalectin":[54],"signature\u201d":[55,217],"human":[58,172],"prostate":[59,80,104,147,168,173,196,223],"cancer":[60,81,105,148,169,174,197],"microenvironment":[61],"with":[62,180],"overarching":[64],"goal":[65],"selecting":[67],"novel-molecular":[68],"targets":[69],"for":[70,231,237],"prognostic":[71],"therapeutic":[73],"purposes.":[74],"In":[75,114,171],"examining":[76],"androgen-responsive":[77],"castration-resistant":[79],"cells":[82,198],"primary":[84],"tumors":[85],"representing":[86],"stages":[88,189,242],"disease,":[91],"we":[92,158],"found":[93],"that":[94,218],"galectin-1":[95],"(Gal-1)":[96],"was":[97,108,138],"most":[99],"abundantly":[100],"expressed":[101,120],"tissue":[106,175],"markedly":[109],"upregulated":[110],"during":[111,131,146],"disease":[112,132,220],"progression.":[113],"contrast,":[115],"all":[116],"other":[117,206],"were":[119,129],"at":[121,154],"lower":[122],"levels:":[123],"Gal-3,":[124],"-4,":[125],"-9,":[126],"-12":[128],"downregulated":[130],"evolution,":[133],"whereas":[134],"expression":[135,178,204],"Gal-8":[137],"unchanged.":[139],"Given":[140],"prominent":[142],"regulation":[143],"Gal-1":[145,177,194,232],"its":[151],"predominant":[152],"localization":[153],"tumor-vascular":[156],"interface,":[157],"analyzed":[159],"potential":[161],"role":[162,230],"endogenous":[165],"lectin":[166],"angiogenesis.":[170],"arrays,":[176],"correlated":[179],"presence":[182],"blood":[184],"vessels,":[185],"particularly":[186],"advanced":[188,241],"disease.":[192,245],"Silencing":[193],"reduced":[199],"vascularization":[201],"without":[202],"altering":[203],"angiogenesis-related":[207],"genes.":[208],"Collectively,":[209],"our":[210],"findings":[211],"identify":[212],"dynamically":[214],"regulated":[215],"\u201cgalectin-specific":[216],"accompanies":[219],"evolution":[221],"cancer,":[224],"they":[226],"highlight":[227],"major":[229],"as":[233],"tractable":[235],"target":[236],"antiangiogenic":[238],"therapy":[239],"Cancer":[246],"Res;":[247],"73(1);":[248],"86\u201396.":[249],"\u00a92012":[250],"AACR.":[251]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-03-31T00:00:00"}